[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO820881L - Fremgangsmaate til fremstilling av nye tiazolderivater. - Google Patents

Fremgangsmaate til fremstilling av nye tiazolderivater.

Info

Publication number
NO820881L
NO820881L NO820881A NO820881A NO820881L NO 820881 L NO820881 L NO 820881L NO 820881 A NO820881 A NO 820881A NO 820881 A NO820881 A NO 820881A NO 820881 L NO820881 L NO 820881L
Authority
NO
Norway
Prior art keywords
hydroxy
formula
atoms
lower alkyl
unsubstituted
Prior art date
Application number
NO820881A
Other languages
English (en)
Norwegian (no)
Inventor
Pier Giorgio Ferrini
Richard Goeschke
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO820881L publication Critical patent/NO820881L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46Oxygen atoms
    • C07D213/50Ketonic radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/30Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/36Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO820881A 1981-03-18 1982-03-17 Fremgangsmaate til fremstilling av nye tiazolderivater. NO820881L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH183881 1981-03-18

Publications (1)

Publication Number Publication Date
NO820881L true NO820881L (no) 1982-09-20

Family

ID=4219779

Family Applications (1)

Application Number Title Priority Date Filing Date
NO820881A NO820881L (no) 1981-03-18 1982-03-17 Fremgangsmaate til fremstilling av nye tiazolderivater.

Country Status (16)

Country Link
US (1) US4451471A (el)
EP (1) EP0061425A3 (el)
JP (1) JPS57183767A (el)
KR (1) KR830009066A (el)
AU (1) AU8166782A (el)
DK (1) DK118482A (el)
ES (8) ES8400102A1 (el)
FI (1) FI820877L (el)
GB (1) GB2098203B (el)
GR (1) GR78347B (el)
HU (1) HU187684B (el)
IL (1) IL65285A (el)
NO (1) NO820881L (el)
NZ (1) NZ200038A (el)
PT (1) PT74593B (el)
ZA (1) ZA821790B (el)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4632930A (en) * 1984-11-30 1986-12-30 E. I. Du Pont De Nemours And Company Antihypertensive alkyl-arylimidazole, thiazole and oxazole derivatives
DE3508666A1 (de) * 1985-03-12 1986-09-18 Hoechst Ag, 6230 Frankfurt Heterocyclische disulfide und ihre anwendung als immunmodulatoren
DE3508665A1 (de) * 1985-03-12 1986-09-18 Hoechst Ag, 6230 Frankfurt Heterocyclische sulfide und ihre anwendung als immunmodulatoren
JPS6339868A (ja) * 1986-08-04 1988-02-20 Otsuka Pharmaceut Factory Inc ジ低級アルキルフエノ−ル誘導体
EP0301613B1 (en) * 1987-07-27 1991-07-10 Duphar International Research B.V Thiazole compounds having fungicidal activity
AT392788B (de) * 1988-02-03 1991-06-10 Fisons Plc Neue benzimidazolverbindungen, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen
DE3807232A1 (de) * 1988-03-05 1989-09-14 Bayer Ag Substituierte acrylsaeureester
JP2933739B2 (ja) * 1990-04-09 1999-08-16 明治製菓株式会社 チアゾールまたはイミダゾール誘導体および抗潰瘍剤
US5255697A (en) * 1991-10-23 1993-10-26 Working Inc. Walking support apparatus
JP2636819B2 (ja) 1994-12-20 1997-07-30 日本たばこ産業株式会社 オキサゾール系複素環式芳香族化合物
CA2381215A1 (en) * 1999-08-06 2001-02-15 Takeda Chemical Industries, Ltd. P38map kinase inhibitors
BRPI0706621A2 (pt) * 2006-01-18 2011-04-05 Amgen Inc composto, composição farmacêutica, métodos para tratar um distúrbio mediado por quinase em um mamìfero e para tratar um distúrbio relacionado com a proliferação em um mamìfero, e , uso do composto
US7919504B2 (en) * 2007-07-17 2011-04-05 Amgen Inc. Thiadiazole modulators of PKB
IN2015DN00202A (el) 2012-07-12 2015-06-12 Chiesi Farma Spa

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2129012A1 (de) * 1971-06-11 1973-01-04 Merck Patent Gmbh Azol-derivate
FR2146161A1 (en) * 1971-07-22 1973-03-02 Roussel Uclaf Thiazolyl thiolacetic acids - analgesics antiinflammatories and antipyretics
US3888870A (en) * 1974-03-08 1975-06-10 Sandoz Ag 2-sulfinyl-thiazoles and oxazoles
US4022607A (en) * 1975-06-09 1977-05-10 Sandoz, Inc. Substituted oxazoles and thiazoles as herbicides

Also Published As

Publication number Publication date
HU187684B (en) 1986-02-28
PT74593A (de) 1982-04-01
ES510504A0 (es) 1983-10-16
ZA821790B (en) 1983-01-26
AU8166782A (en) 1982-09-23
ES8601171A1 (es) 1985-10-16
ES522868A0 (es) 1985-02-01
ES537342A0 (es) 1986-01-16
ES8603847A1 (es) 1986-01-01
IL65285A (en) 1985-11-29
EP0061425A2 (de) 1982-09-29
ES8503677A1 (es) 1985-03-16
GB2098203A (en) 1982-11-17
GR78347B (el) 1984-09-26
ES8603499A1 (es) 1985-12-16
ES537278A0 (es) 1985-12-16
NZ200038A (en) 1985-05-31
IL65285A0 (en) 1982-05-31
ES8604180A1 (es) 1986-01-16
GB2098203B (en) 1985-05-09
KR830009066A (ko) 1983-12-17
EP0061425A3 (de) 1982-12-15
DK118482A (da) 1982-09-19
ES522869A0 (es) 1985-03-16
ES537343A0 (es) 1985-10-16
US4451471A (en) 1984-05-29
ES537277A0 (es) 1986-01-01
PT74593B (de) 1984-11-27
ES8400102A1 (es) 1983-10-16
JPS57183767A (en) 1982-11-12
ES8502980A1 (es) 1985-02-01
FI820877L (fi) 1982-09-19
ES8603498A1 (es) 1985-12-16
ES522867A0 (es) 1985-12-16

Similar Documents

Publication Publication Date Title
NO820881L (no) Fremgangsmaate til fremstilling av nye tiazolderivater.
SI9111647A (en) Unsaturated hydroxyalkylquinoline acids
US4302461A (en) Antiinflammatory 5-substituted-2,3-diarylthiophenes
JP2014513074A (ja) ウィルス複製の阻害剤、それらの調製方法及びそれらの治療的使用
IE46454B1 (en) Anti-inflamatory 1-substituted-4,5-diaryl-2-(substituted thio) imidazoles and their corresponding sulfoxides and sulfones
NO810064L (no) Fremgangsmaate for fremstilling av fysiologisk aktive pyrimidin-2-sulfider og s-oksyder derav
KR910002824B1 (ko) 피리딘유도체 및 그것을 함유하는 궤양치료제
EP0295049B1 (en) Thiophene sulfonamide antiglaucoma agents
NO168355B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
KR820002315B1 (ko) 메르캅토이미다졸 유도체의 제조방법
NO171412B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksatiolan- eller 1,3-ditiolanderivater
US4654358A (en) 1,4,5-triphenylimidazol-2-yl mercapto alkanoic acids, useful against inflammation and diseases responding to lipid lowering
US4159338A (en) Antiinflammatory-4,5-dicyclic-2-(substituted thio)-imidazoles and their corresponding sulfoxides and sulfones
IE55484B1 (en) Dithio compounds,pharmaceutical preparations containing them and their use
US4355034A (en) Ethenyl derivatives of mercaptoalkylpyridines as anti-inflammatory agents
US5102905A (en) Thienyl benzothienyl and dibenzothienyl compounds as inhibitors of aldose reductase
GB2061928A (en) Anti-inflammatory and immunoregulatory pyridines and pyrimidines
CA1105024A (en) Anti-inflammatory-4,5-dicyclic-2-(substituted thio) imidazoles and their corresponding sulfoxides and sulfones
EP0150461A2 (de) Schwefelhaltige 6-Ketoprostaglandine
KR960012367B1 (ko) 2-알킬설피닐-4(3h)-퀴나졸리논 유도체, 이의 제조방법 및 약제학적 조성물
DD202705A5 (de) Verfahren zur herstellung neuer thiazolderivate
NO851035L (no) Fremgangsmaate til fremstilling av nye 1,2,4-triazacykloalkaderivater
US4193928A (en) Lasalocid derivatives
NO812790L (no) Nye diaryl-imidazol-forbindelser, fremgangsmaate til deres fremstilling, farmasoeytiske preparater som inneholder disse og deres anvendelse
CZ281857B6 (cs) 3,4-Dihydro-2-alkyl-3-oxo-N-aryl-2H-[1]benzothieno[3,2-e]-1,2-thiazin-4-karboxamid-1,1-dioxidy, způsob jejich přípravy, meziprodukty tohoto způsobu, farmaceutický prostředek a použití